Author:
Tomáš Tomáš,Apostolopoulos Vasileios,Pazourek Lukáš,Kubíček Marián,Staniczková Zambo Iva,Adámková Dagmar,Šlampa Pavel,Mahdal Michal
Abstract
AbstractMyxofibrosarcoma presents an infiltrating growth pattern that results in a high tendency for local recurrence. Clear margin resection is challenging because of microscopic infiltration. The purpose of the present study was to analyze the overall and disease-free survival rates of patients with myxofibrosarcoma and the prognostic factors that determine both survival and disease recurrence. Among the 111 patients included in our study, the 5-year overall survival rate was 65.5%. An age of more than 65 years (hazard ratio [HR] 1.9 [95% confidence interval (CI) 1.4–5.6]; p < 0.001), a tumor size of more than 5 cm (HR 2.8 [95% CI 0.9–8.1]; p = 0.049) and the G3 tumor grade (HR 14.1 [95% CI 2.1–105.0]; p < 0.001) negatively affected overall survival. The 5-year recurrence-free survival rate was 49.4%. R1/R2-type resection (HR 2.4 [95% CI 1.0–5.6]; p = 0.048) had a detrimental effect on tumor recurrence. Clear margins had a positive impact on recurrence-free survival, but did not significantly affect overall patient survival, suggesting that other factors may play a more significant role in determining patient outcomes. A surgical margin of 2 mm was not sufficient to significantly influence the incidence of recurrence. Consequently, a wider surgical margin may be necessary to reduce the risk of myxofibrosarcoma recurrence.
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Weiss, S. W. & Enzinger, F. M. Myxoid variant of malignant fibrous histiocytoma. Cancer 39, 1672–1685 (1977).
2. Angervall, L., Kindblom, L. G. & Merck, C. Myxofibrosarcoma. A study of 30 cases. Acta Pathol. Microbiol. Scand. A 85A, 127–140 (1977).
3. Meis-Kindblom, J. M. & Kindblom, L. G. Acral myxoinflammatory fibroblastic sarcoma: A low-grade tumor of the hands and feet. Am. J. Surg. Pathol. 22, 911–924 (1998).
4. WHO. Classification of Tumours of Soft Tissue and Bone (IARC Press, 2013).
5. Vanni, S. et al. Myxofibrosarcoma landscape: Diagnostic pitfalls, clinical management and future perspectives. Ther. Adv. Med. Oncol. 14, 175883592210939 (2022).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献